The original success of Viagra undeniably transformed the medication landscape, but placing funds in companies strongly reliant on off-patent versions presents a complex picture. Despite early returns were impressive, the expiration of patents and the rise of discounted alternatives have weakened market share. Consequently, a thorough analysis of c